CAR--话题@MedSci

#CAR-#

459篇内容 | 2240人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1781471, encodeId=60e91e81471bf, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=FDA公布基因编辑与CAR-T细胞疗法两份指南草案，提出这些建议, objectType=article, longId=301462, objectId=79c4301462ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79c4301462ab, replyNumber=0, likeNumber=70, createdTime=2022-04-08, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79c4301462ab, moduleTitle=FDA公布基因编辑与CAR-T细胞疗法两份指南草案，提出这些建议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79c4301462ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781492, encodeId=ac991e8149288, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=驯鹿生物与信达生物共同开发的全人源BCMA CAR-T细胞伊基仑赛注射液新药申请上市, objectType=article, longId=728560, objectId=ec8be2856007, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec8be2856007, replyNumber=0, likeNumber=87, createdTime=2022-08-29, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec8be2856007, moduleTitle=驯鹿生物与信达生物共同开发的全人源BCMA CAR-T细胞伊基仑赛注射液新药申请上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec8be2856007)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781474, encodeId=291b1e81474bf, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=【Nature子刊】24小时生成CAR-T细胞，造福更多患者！, objectType=article, longId=302095, objectId=9d48302095fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d48302095fe, replyNumber=0, likeNumber=55, createdTime=2022-12-16, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d48302095fe, moduleTitle=【Nature子刊】24小时生成CAR-T细胞，造福更多患者！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d48302095fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781515, encodeId=fdf41e815150f, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Science子刊：山东大学姜新义等开发CAR-巨噬细胞在体编辑新策略，用于胶质瘤术后免疫治疗, objectType=article, longId=735079, objectId=ad43e350798e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad43e350798e, replyNumber=0, likeNumber=101, createdTime=2022-11-05, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad43e350798e, moduleTitle=Science子刊：山东大学姜新义等开发CAR-巨噬细胞在体编辑新策略，用于胶质瘤术后免疫治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad43e350798e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781510, encodeId=8f1c1e81510be, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=细数CAR-NK：从生物学到未来展望, objectType=article, longId=733649, objectId=ef64e3364983, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef64e3364983, replyNumber=0, likeNumber=78, createdTime=2023-04-15, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef64e3364983, moduleTitle=细数CAR-NK：从生物学到未来展望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef64e3364983)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781499, encodeId=406e1e8149969, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=现货型CAR-T疗法的危机：Cas9基因编辑后，T细胞繁现染色体异常, objectType=article, longId=731446, objectId=0e9de3144639, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e9de3144639, replyNumber=0, likeNumber=62, createdTime=2023-02-08, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e9de3144639, moduleTitle=现货型CAR-T疗法的危机：Cas9基因编辑后，T细胞繁现染色体异常, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e9de3144639)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781509, encodeId=07b21e8150960, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=中科院在提升CAR-T细胞抗异质性肿瘤活性方面取得新进展, objectType=article, longId=733438, objectId=99ece33438eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99ece33438eb, replyNumber=0, likeNumber=103, createdTime=2022-12-31, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99ece33438eb, moduleTitle=中科院在提升CAR-T细胞抗异质性肿瘤活性方面取得新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=99ece33438eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781458, encodeId=dcdc1e814581a, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Science封面重磅：mRNA注射可在体内直接制造CAR-T细胞，一针修复心脏, objectType=article, longId=293586, objectId=ca19293586d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca19293586d0, replyNumber=0, likeNumber=64, createdTime=2022-07-10, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca19293586d0, moduleTitle=Science封面重磅：mRNA注射可在体内直接制造CAR-T细胞，一针修复心脏, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca19293586d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781513, encodeId=fd0e1e81513d0, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=【Blood Cancer J】CAR-T治疗非霍奇金淋巴瘤的治疗相关髓系肿瘤, objectType=article, longId=734614, objectId=f1cae346148a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1cae346148a, replyNumber=0, likeNumber=76, createdTime=2022-11-12, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1cae346148a, moduleTitle=【Blood Cancer J】CAR-T治疗非霍奇金淋巴瘤的治疗相关髓系肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1cae346148a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781484, encodeId=42421e81484e8, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=通用型CAR-NK用于复发/难治性急性髓系白血病（AML），3/5例获得CR, objectType=article, longId=725531, objectId=3a03e2553107, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a03e2553107, replyNumber=0, likeNumber=67, createdTime=2022-06-03, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a03e2553107, moduleTitle=通用型CAR-NK用于复发/难治性急性髓系白血病（AML），3/5例获得CR, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a03e2553107)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781483, encodeId=0cc91e8148350, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=【4月25日（周一）19:00星光奕奕】CAR-T中国病例分享会即将开始！——当CAR-T之光照进现实，恶性血液病的临床治愈将成为可能！, objectType=article, longId=724918, objectId=d4d0e249186c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4d0e249186c, replyNumber=0, likeNumber=60, createdTime=2022-05-01, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4d0e249186c, moduleTitle=【4月25日（周一）19:00星光奕奕】CAR-T中国病例分享会即将开始！——当CAR-T之光照进现实，恶性血液病的临床治愈将成为可能！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4d0e249186c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781472, encodeId=be1e1e8147272, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Nature子刊：可植入生物技术产生CAR-T细胞，治疗癌症更快、更有效！, objectType=article, longId=301719, objectId=91d0301e196f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=91d0301e196f, replyNumber=0, likeNumber=62, createdTime=2022-09-17, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91d0301e196f, moduleTitle=Nature子刊：可植入生物技术产生CAR-T细胞，治疗癌症更快、更有效！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=91d0301e196f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781517, encodeId=cd751e81517d9, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=一文带你认清CAR-T、CAR-NK和CAR-M细胞治疗, objectType=article, longId=735395, objectId=c9abe353958c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c9abe353958c, replyNumber=0, likeNumber=80, createdTime=2023-01-10, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c9abe353958c, moduleTitle=一文带你认清CAR-T、CAR-NK和CAR-M细胞治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c9abe353958c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781466, encodeId=66001e814666e, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=FDA批准传奇生物首款CAR-T细胞治疗产品CARVYKTI®(西达基奥仑赛)上市, objectType=article, longId=299876, objectId=e4402998e658, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4402998e658, replyNumber=0, likeNumber=103, createdTime=2022-05-23, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4402998e658, moduleTitle=FDA批准传奇生物首款CAR-T细胞治疗产品CARVYKTI®(西达基奥仑赛)上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4402998e658)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781479, encodeId=a3d81e81479fe, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Science子刊：利用水凝胶递送CAR-T细胞可改善对实体瘤的治疗, objectType=article, longId=724214, objectId=9a47e24214ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a47e24214ee, replyNumber=0, likeNumber=83, createdTime=2022-05-21, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a47e24214ee, moduleTitle=Science子刊：利用水凝胶递送CAR-T细胞可改善对实体瘤的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a47e24214ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781521, encodeId=2f091e81521fc, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=在CAR-NK细胞治疗中克服肿瘤耐药机制, objectType=article, longId=737938, objectId=26a6e37938f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26a6e37938f1, replyNumber=0, likeNumber=77, createdTime=2023-03-23, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26a6e37938f1, moduleTitle=在CAR-NK细胞治疗中克服肿瘤耐药机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26a6e37938f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781500, encodeId=d6bc1e8150078, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CAR-T新突破：治疗获益所需细胞量减少5倍，这一蛋白功劳大 | Nature子刊, objectType=article, longId=731696, objectId=5a79e31696ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a79e31696ef, replyNumber=0, likeNumber=62, createdTime=2023-04-10, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a79e31696ef, moduleTitle=CAR-T新突破：治疗获益所需细胞量减少5倍，这一蛋白功劳大 | Nature子刊, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a79e31696ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781503, encodeId=ebfd1e81503f2, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Treg的未来：CAR-Treg, objectType=article, longId=731976, objectId=6d78e31976cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d78e31976cc, replyNumber=0, likeNumber=96, createdTime=2023-01-20, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d78e31976cc, moduleTitle=Treg的未来：CAR-Treg, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d78e31976cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781489, encodeId=04131e814890a, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=AJH：针对 B 细胞成熟抗原的 CAR-T 细胞疗法对复发/难治性多发性骨髓瘤有效，包括体能状态不佳的病例, objectType=article, longId=726769, objectId=f014e26769c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f014e26769c3, replyNumber=0, likeNumber=60, createdTime=2023-03-06, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f014e26769c3, moduleTitle=AJH：针对 B 细胞成熟抗原的 CAR-T 细胞疗法对复发/难治性多发性骨髓瘤有效，包括体能状态不佳的病例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f014e26769c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781508, encodeId=14391e8150843, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Molecular Therapy : 关闭EBAG9基因，增强CAR-T效果, objectType=article, longId=733153, objectId=0a19e3315315, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a19e3315315, replyNumber=0, likeNumber=77, createdTime=2022-11-08, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a19e3315315, moduleTitle=Molecular Therapy : 关闭EBAG9基因，增强CAR-T效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a19e3315315)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CAR-

2020-05-29

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

FDA公布基因编辑与CAR-T细胞疗法两份指南草案，提出这些建议

2022-04-08

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

驯鹿生物与信达生物共同开发的全人源BCMA CAR-T细胞伊基仑赛注射液新药申请上市

2022-08-29

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

【Nature子刊】24小时生成CAR-T细胞，造福更多患者！

2022-12-16

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Science子刊：山东大学姜新义等开发CAR-巨噬细胞在体编辑新策略，用于胶质瘤术后免疫治疗

2022-11-05

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

细数CAR-NK：从生物学到未来展望

2023-04-15

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

现货型CAR-T疗法的危机：Cas9基因编辑后，T细胞繁现染色体异常

2023-02-08

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

中科院在提升CAR-T细胞抗异质性肿瘤活性方面取得新进展

2022-12-31

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Science封面重磅：mRNA注射可在体内直接制造CAR-T细胞，一针修复心脏

2022-07-10

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

【Blood Cancer J】CAR-T治疗非霍奇金淋巴瘤的治疗相关髓系肿瘤

2022-11-12

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

通用型CAR-NK用于复发/难治性急性髓系白血病（AML），3/5例获得CR

2022-06-03

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

【4月25日（周一）19:00星光奕奕】CAR-T中国病例分享会即将开始！——当CAR-T之光照进现实，恶性血液病的临床治愈将成为可能！

2022-05-01

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Nature子刊：可植入生物技术产生CAR-T细胞，治疗癌症更快、更有效！

2022-09-17

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

一文带你认清CAR-T、CAR-NK和CAR-M细胞治疗

2023-01-10

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

FDA批准传奇生物首款CAR-T细胞治疗产品CARVYKTI®(西达基奥仑赛)上市

2022-05-23

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Science子刊：利用水凝胶递送CAR-T细胞可改善对实体瘤的治疗

2022-05-21

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

在CAR-NK细胞治疗中克服肿瘤耐药机制

2023-03-23

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

CAR-T新突破：治疗获益所需细胞量减少5倍，这一蛋白功劳大 | Nature子刊

2023-04-10

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Treg的未来：CAR-Treg

2023-01-20

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

AJH：针对 B 细胞成熟抗原的 CAR-T 细胞疗法对复发/难治性多发性骨髓瘤有效，包括体能状态不佳的病例

2023-03-06

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Molecular Therapy : 关闭EBAG9基因，增强CAR-T效果

2022-11-08

科室
- - 订阅+
  - 更多科室
工具
服务